References
 

References/Diabetology:

1. Julius S, Valentini M: Consequences of the increased autonomic nervous drive in hypertension, heart failure and diabetes. Blood Press Suppl 1998; 7(3): 5-13.
2. Data on file
3. Ziegler D et al: Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis. Amd standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 1992; 9(9): 806-814.
4. American Diabetes Association. Diabetic Neuropathy. In: Clinical practice recommendations 1996. Diabetes Care 19; 1996 (Suppl.1): S67-S92.
5. The Writing Team for the DCCT / EDIC Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287(19): 2563-9.
6. Ziegler D: Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 1999; 7: 342-57.
7. Pagani M: Heart rate variability and autonomic diabetic neuropathy. Diabetes Nutr Metab 2000; 13(6): 341-6.
8. O'Brien IA et al: The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med, 79/290; 1991: 495-502
9. Ewing DJ et al: The natural history of diabetic autonomic neuropathy. Q J Med 193; 1980: 95-108.
10. Hecht MJ et al: Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol Res 2001; 23(6): 651-654.

10. Molgaard H et al: Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? Diabetologia 37; 1994: 788-96.
11. Poulsen PL et al: 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 40; 1997: 718-725.
12. Meinhold JA et al: Low prevalence of cardiac autonomic neuropathy in Type 1 diabetic patients without nephropathy. Diabetic Med 2001; 18: 607-613.
13. Sundkvist G, Lilja B: Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993; 16/5: 773-9.
14. Takahashi N et al: Effect of essential hypertension on cardiac autonomic function in type 2 diabetes patients. J Am Coll Cardiol 2001; 38: 232-237.
15. Stamler et al: Diabetes, other risk factors, and the 12-year cardiovascular mortality for men screened in the multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
16. Valensi P et al: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 2001; 24: 339-343.
17. Andersson B et al: Urinary albumin excretion and heart rate variability in obese women. Int J Obes Relat Metab Disord, 1998; 22(5):399-405.
18. Yakinci C et al: Autonomic nervous system functions in obese children. Brain Dev 2000; 22(3): 151-153.
19. Nakano Y et al: Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity. J Cardiovasc Pharmacol 2001; 38 (Suppl 1): S69-74.
20. Liao D et al: Multiple metabolic syndrome is associated with lower heart rate variability: The Atherosclerosis Risk in Communities Study. Diabetes Care 1998;21(12):2116-22.
21. Cacciatori V et al: Power spectral analysis of heart rate in hypothyroidism. Eur J Endocrinol 2000; 143(3): 327-333.
22. Rosano GM et al: Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol 1997; 80(6): 815-7.
23. Birner P et al: Cardiac autonomic function in patients suffering from primary focal hyperhidrosis. Eur Neurol 2000; 44: 112-116.
24. Chaudhuri KR. Autonomic dysfunction in movement disorders. Curr Opin Neurol 2001; 14(4): 505-511.
25. Rockel A et al: Uraemic sympathetic neuropathy after haemodialysis and transplanting. Eur J Clin Invest 1979; 9: 23-27.
26. Vita G et al: Comparative analysis of autonomic and somatic dysfunction in chronic uraemia. Eur Neurol 1988; 28: 335-340.
27. Dillon Jf et al: Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24 hour heart rate variability. Am J
Gastroent 1994; 89: 1544-1547.
28. Watson JP et al: Autonomic dysfunction in patients with nocturnal hypoventilation in extrapulmonary restrictive disease. Eur Respir J 1999; 13: 1097-1102.
29. Neild PJ et al: Cardiac autonomic function in AIDS is not secondary to heart failure. Int J Cardiol 2000; 74: 133-137.
30. Rapenne T et al: Could heart rate variability analysis become an early predictor of imminent brain death? A pilot study. Anesth Analg 2000; 91: 329-336 .
31. Dillon JF et al: The correction of autonomic dysfunction in cirrhosis by captopril. J Hepatol 1997; 26: 331-335.
32. Burger AJ et al: Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999; 84(6): 687-91.
33. European Heart Failure Training Group: Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. Eur Heart J 1998; 19(3): 466-75.
34. Malfatto G et al: Short and long term effects of exercise training on the tonic autonomic modulation of heart rate variability after myocardial infarction. Eur Heart J 1996;17(4): 532-8.
35. Benarroch EE: The central autonomic network: Functional organization, dysfunction, and perspective. Mayo Clin Proc 1993; 68(10): 988-1001.
36. Ewing DJ et al: Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. An Intern Med 1980; 92(Pt 2): 308-11.
37. Ewing DJ et al: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8/5: 491-8.
38. Weston PJ et al: Evidence of defective cardiovascular regulation in insulin-dependent diabetic patients without clinical autonomic dysfunction. Diabetes Res Clin Pract 1998; 42/3: 141-148.
39. Hayano JI et al: Postural response of low-frequency component of heart rate variability is an increased risk for mortality in patients with coronary artery disease. Chest 2001; 120(6): 1942-1952.
40. Howorka K et al: Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst 1998; 69/2-3: 164-172.
41. Ziegler D: Clinical ascpects, diagnosis and therapy of diabetic neuropathy. Ther Umsch 1996; 53(12): 948-57.
42. Howorka K et al: Influence of fasting on heart rate variability in diabetic patients with different degrees of cardiovascular autonomic neuropathy. Diabetes Nutr Metab/Clin Exp 1997; 10: 288-295.
43. Howorka K et al: Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res 1997; 34: 206-214.
44. Ziegler D et al: Effects of treatment with the antioxidant a-lipoic acid on cardiac autonomic neuropathy in NIDDM patients: A 4-month randomized controlled multicenter trial (DEKAN study). Diabetes Care 1997; 20(3): 369-373.
45. Boulton AJM: Current and emerging treatments for the diabetic neuropathies. Diabetes Reviews 1999; 7(4): 379-386.
46. Vinik et al: Gastrointestinal, genitourinary, and neurovascular disturbances in diabetes. Diabetes Reviews 1999; 7(4): 358-378.
 
All material contained within this website is copyrighted to Advanced Medical Diagnostic Group Limited.
Varia Cardio ® and VariaPulse are registered trademarks of AMDG Ltd. This product is protected by patents owned by AMDG Ltd.

Manufactured for AMDG by MIE Medical Research Ltd (an ISO13488 accredited company). AMDG and MIE Research Ltd reserve the right to amend specifications without notice in accordance to their policy of continual product improvement.
 
© 2001-5 Advanced Medical Diagnostics Group Ltd. All Rights Reserved.
 

AMDG Ltd, 6 Wortley Moor Road, Leeds, LS12 4JF
Tel: +44 (0) 113 279 1010 Fax: +44 (0) 113 231 0820
Contact Us